News

September 17, 2014 — A new clinical trial found that vascular closure devices (VCDs) are non-inferior to manual compression in patients undergoing transfemoral coronary angiography. The findings...

Cardiva Medical Inc. Vascade Vascular Closure System Series 3 financing U.S.

Cardiva Medical Inc. said it closed the first two tranches of a $16.5 million Series 3 private equity financing and a $12.5 million senior secured facility with GE Capital. The company will use...

Transluminal Technologies LLC CE mark velox CD Vascular Closure Device

Transluminal Technologies LLC, a Syracuse, NY-based medical device company, received CE mark approval for the velox CD Vascular Closure Device. 

Mynx Vascular Closure Device Cardinal Health 2 Millionth Shipment June 2014

Cardinal Health announced the 2 millionth shipment of the Mynx Vascular Closure Device (VCD).

Cardinal Health AccessClosure Acquisition Vascular Closure Devices Cath Lab

Cardinal Health announced an agreement to acquire privately held AccessClosure Inc. for $320 million. 

AccessClosure Next-Generation Vascular Closure Device ACC.14 March 2014

AccessClosure Inc. commercially launched itsMynx Ace vascular closure device, a safe and secure vascular closure product that provides consistent results with a new, easy-to-use deployment system...

AccessClosure Mynx Ace Vascular Closure Device Hemostasis Management Cath Lab

AccessClosure plans to launch the Mynx Ace Vascular Closure Device at the 2014 American College of Cardiology meeting, March 29-31. It is an upgrade of the company’s Mynx mechanical ...

Vascular closure devices have a definite niche in areas where they were not originally intended but have found frequent off-label use because of their utility.

vascular closure device

Vascular closure devices (VCD) were first introduced in the early 1990s with a goal to achieve quick hemostasis, thus reducing patients’ stay in the hospital (shorter time to ambulation) as...

The U.S. District Court for the District of New Jersey approved an agreement under which Vascular Solutions Inc. will cease further manufacture, sales and distribution of its R-Band Radial...

CardioLogical Solutions is an emerging cardiovascular device company formed by the merger of Emboline and VasoStitch and its breakthrough platform of accessory devices for transcatheter aortic...

Cardiva Medical FDA Pre Market Approval Vascade VCS

Cardiva Medical Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Premarket Approval (PMA) for the Vascade Vascular Closure System (VCS). Clinical data from a prospective...

Vascular Closure Systems Inc. announced the successful conclusion of Phase I and Phase II of the first-in-human (FIH) clinical trial for its 6/7 French FastSeal Bioabsorbable Vascular Access...

November 6, 2012 — Vascular Solutions launched the R-Band radial hemostasis compression device in the United...

 An extracted bovine artery with an arteriotomy sealed by a MynxGrip closure dev

Vascular closure devices that use an active method to immediately seal the femoral access site can enable faster patient ambulation, reduce nursing time and speed discharge. However, one of...

Due to the increasing number of transcatheter aortic valve replacements (TAVR) and endovascular aneurysm repair (EVAR), a new startup company has developed a transfemoral combined access and...

July 6, 2012 — Vascular Closure Systems Inc. announced that the 30-day follow-up results for the Phase I first-in-human (FIH) clinicals have been confirmed by Doppler and ultrasound evaluation....

June 4, 2012 — SentreHeart Inc., a privately held medical device company, announced that it has recently completed a $26 million Series C financing led by Vivo Ventures, with participation by its...

May 4, 2012 - CardioDex announces initial commercial use of a new femoral access site closure device. Recent data from commercial use of the device on 41 patients at St. Marien Hospital in Siegen...

April 20, 2012 — VasoStitch will be featuring its technology at EuroPCR, Europe’s largest interventional cardiology scientific meeting, May 17, in Paris.